Research Article
Danshen (Salvia miltiorrhiza) Compounds Improve the Biochemical Indices of the Patients with Coronary Heart Disease
Table 3
Biochemical indices measure after three-month run-in period, median (range), mg/dL.
| | Danshen group () | Placebo group () | values |
| Lipid profile | | | | LDL cholesterol | 113 (90–147) | 120 (91–150) | 0.324 | HDL cholesterol | 55 (44–68) | 51 (47–65) | 0.512 | Total cholesterol | 190 (172–234) | 189 (176–248) | 0.763 | Triglycerides | 114 (87–173) | 118 (82–166) | 0.262 | Apolipoprotein A | 98 (82–126) | 99 (85–128) | 0.899 | Apolipoprotein B | 76 (66–103) | 78 (62–109) | 0.842 | Apolipoprotein E | 7.0 (5.8–8.5) | 7.2 (5.4–8.8) | 0.763 | Lipoprotein (a) | 32 (22–45) | 34 (25–48) | 0.268 | Liver function | | | | Gamma-glutamyl transpeptidase (IU/dL) | 3.3 (2.5–5.4) | 3.1 (2.5–5.3) | 0.275 | Total bilirubin | 0.5 (0.4–0.7) | 0.6 (0.4–0.8) | 0.431 | Indirect bilirubin | 0.5 (0.3–0.5) | 0.4 (0.3–0.5) | 0.176 | Direct bilirubin | 0.4 (0.2–0.6) | 0.4 (0.2–0.5) | 0.185 | Renal function | | | | Uric acid | 5.1 (4.2–6.8) | 5.3 (4.2–6.4) | 0.267 | Risk factor of heart disease | | | | Homocysteine | 23 (20–43) | 25 (20–46) | 0.341 |
|
|